Evidence-based mini-review: Should patients over the age of 60 with INT-2 or high-risk myelodysplastic syndrome undergo allogeneic stem cell transplantation prior to progression to acute myelogenous leukemia?
Evidence-based mini-review: Should patients over the age of 60 with INT-2 or high-risk myelodysplastic syndrome undergo allogeneic stem cell transplantation prior to progression to acute myelogenous leukemia?
复制标题
循证小型回顾：60岁以上患有INT-2或高危骨髓增生异常综合征的患者在进展为急性髓性白血病之前是否应该接受同种异体干细胞移植？
DOI：
10.1182/asheducation-2010.1.322
复制
发表时间：
2010
期刊：
影响因子：
--
通讯作者：
Blum,William
中科院分区：
文献类型：
--
作者：
Schroeder,MarkA;Blum,William
